Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Christiane Querfeld(City of Hope), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Abhinita Mohanty(Memorial Sloan Kettering Cancer Center), Patrizia Mondello(WinnMed), Peter C. Louis(Vanderbilt University Medical Center), Alison J. Moskowitz, Natasha Galasso(Memorial Sloan Kettering Cancer Center), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Franck Rapaport(Memorial Sloan Kettering Cancer Center), Marina P. Siakantaris(National and Kapodistrian University of Athens), Patricia L. Myskowski(Memorial Sloan Kettering Cancer Center), Marcel R.M. van den Brink(City Of Hope National Medical Center), Francesco Maura(Memorial Sloan Kettering Cancer Center), Melissa Pulitzer(Memorial Sloan Kettering Cancer Center)
Cited by 12
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
|Proceedings of the National Academy of Sciences|2012|990